Association of Azithromycin With Mortality and Cardiovascular Events Among Older Patients Hospitalized With Pneumonia | Zendy

Eric M. Mortensen | Zendy; Ethan A. Halm | Zendy; Mary Jo Pugh | Zendy; Laurel A. Copeland | Zendy; Mark L. Metersky | Zendy; Michael J. Fine | Zendy; Christopher S. Johnson | Zendy; Carlos Álvarez | Zendy; Christopher R. Frei | Zendy; Chester B. Good | Zendy; Marcos I. Restrepo | Zendy; John R. Downs | Zendy; Antonio Anzueto | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Association of Azithromycin With Mortality and Cardiovascular Events Among Older Patients Hospitalized With Pneumonia

Author(s) -

Eric M. Mortensen,

Ethan A. Halm,

Mary Jo Pugh,

Laurel A. Copeland,

Mark L. Metersky,

Michael J. Fine,

Christopher S. Johnson,

Carlos Álvarez,

Christopher R. Frei,

Chester B. Good,

Marcos I. Restrepo,

John R. Downs,

Antonio Anzueto

Publication year - 2014

Publication title -

jama

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.688

H-Index - 680

eISSN - 1538-3598

pISSN - 0098-7484

DOI - 10.1001/jama.2014.4304

Subject(s) - medicine , azithromycin , pneumonia , propensity score matching , veterans affairs , odds ratio , retrospective cohort study , myocardial infarction , community acquired pneumonia , confounding , guideline , intensive care medicine , antibiotics , biology , pathology , microbiology and biotechnology

Although clinical practice guidelines recommend combination therapy with macrolides, including azithromycin, as first-line therapy for patients hospitalized with pneumonia, recent research suggests that azithromycin may be associated with increased cardiovascular events.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research